← Open Payments lookup

KATIE CREIGHTON: Open Payments

NPI 1467717298 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,237 in 94 payments from 28 companies in 2025. Trend: 2023 $2,069 · 2024 $2,264 · 2025 $2,237

Food & beverage: $2,177Education: $60
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$434
ABBVIE INC.18$262
PFIZER INC.9$222
Amgen Inc.11$207
Teva Pharmaceuticals USA, Inc.6$135
Sumitomo Pharma America, Inc.5$126
Novo Nordisk Inc5$84
Astellas Pharma US Inc2$77
Corcept Therapeutics3$67
Otsuka America Pharmaceutical, Inc.3$64

Products named: BREZTRI, AUSTEDO XR, AIRSUPRA, GEMTESA, KRYSTEXXA, REXULTI, UBRELVY, VRAYLAR.

Industry payments across MD — which companies pay providers there.